International Delphi Consensus on Medial Meniscal Root Tears Shows High Agreement on Diagnosis, Treatment, and Rehabilitation but Lack of Agreement on Treatment of Asymptomatic Tears.

Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.

Abstract

[Indexed for MEDLINE] Conflict of interest statement: Disclosures The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: B.B. received payment for lectures/faculty involvement from Smith & Nephew and Ortomedic and is in the board/editorial boards of European Society of Sports Traumatology, Knee Surgery and Arthroscopy, Journal of ISAKOS, Knee Surgery; Sports Traumatology; Arthroscopy; American Journal of Sports Medicine, and Video Journal of Sports Medicine. J.C. reports board or committee member, American Orthopaedic Society for Sports Medicine, Arthroscopy Association of North America, and International Society of Arthroscopy, Knee Surgery, and Orthopaedic Sports Medicine; paid consultant for Arthrex, CONMED Linvatec, Ossur, and RTI Surgical; hospitality payments from Breg, DePuy Synthes Sales, Joint Restoration Foundation, Medical Device Business Services, Pacira Pharmaceuticals Incorporated, and SI-Bone; educational support from Midwest; paid consultant; paid presenter or speaker Associates for Smith & Nephew; and paid consultant, hospitality payments from Vericel Corporation. C.M.L. reports other financial or material support from Arthrex; paid presenter or speaker for DJ Orthopaedics; paid consultant and IP royalties from Ossur; and IP royalties, other financial or material support from, and paid consultant for Smith & Nephew. A.G.G. has received consulting fees from Smith & Nephew, speaking fees from Ossur and Arthrex, and support for education from Stryker Corporation and Medwest Associates. A.G. reports editorial or governing board of the American Journal of Sports Medicine and Knee Surgery, Sports Traumatology, Arthroscopy; IP royalties from Graymont; board or committee member of the International Society of Arthroscopy, Knee Surgery, and Orthopaedic Sports Medicine; stock or stock options from LinkX Robotics; Ostesys Robotics; Precision OS; Smart HTO; Spring Loaded Technologies, and Surgical Health Innovations Corp; paid consultant, paid presenter or speaker, and research support from Smith & Nephew and research support from Ossur. D.L.J. reports board or committee member, American Orthopaedic Society for Sports Medicine and Southern Orthopaedic Association; research support from DJ Orthopaedics and Smith & Nephew Endoscopy; publishing royalties, financial or material support from Elsevier; editorial or governing board of Journal of Surgical Orthopaedic Advances, Orthopedics, Orthopedics Today, Sports Medicine and Arthroscopy Review, and SLACK Incorporated; IP royalties from Smith & Nephew; and paid consultant for Smith & Nephew Endoscopy. A.K. reports editorial or governing board of the American Journal of Sports Medicine and Springer; IP royalties from and paid consultant for Arthrex; and board or committee member of the Arthroscopy Association of North America and the International Cartilage Repair Society. R.F.L. reports consulting or advisory with Ossur Americas, Smith & Nephew, Linvatec Europe, and Responsive Arthroscopy and funding grants from Ossur Americas, Smith & Nephew, Arthroscopy Association of North America, and American Orthopaedic Society for Sports Medicine. M.L. reports educational services for Smith & Nephew. T.L. reports paid presenter or speaker for Arthrex; board or committee member of the International Society of Arthroscopy, Knee Surgery, and Orthopaedic Sports Medicine; paid consultant and paid presenter or speaker for Medacta; and paid consultant, paid presenter or speaker, and research support from Smith & Nephew. D.P. reports board or committee member of the ACL Study Group, Asia Pacific Knee Arthroscopy and Sports Medicine Society, and Asia Pacific Knee Society, and International Society of Arthroscopy, Knee Surgery, and Orthopaedic Sports Medicine; editorial or governing board of the American Journal of Sports Medicine, Orthopaedic Journal of Sports Medicine, Journal of ISAKOS, and SMARTT Journal; stock or stock options; unpaid consultant for Ganymed Robotics; stock or stock options from Personalised Surgery; paid consultant; paid presenter or speaker for Smith & Nephew; and research support from Zimmer. W.P. reports paid presenter or speaker for Arthrex and Geistlich; board or committee member of Deutsche Kniegesellschaft and GOTS; IP royalties from Karl Storz; editorial or governing board of Kniejournal; and paid consultant for OPED, Valley, Germany. R.S. reports paid presenter or speaker for Arthrex and Smith & Nephew and editorial or governing board of Knee Surgery, Sports Traumatology, Arthroscopy. B.S-C. reports stock or stock options with AREAS and IP royalties from and paid consultant for Arthrex. T.S. reports IP royalties from and paid presenter or speaker for CONMED Linvatec; paid consultant and paid presenter or speaker for Episurf; board or committee member of the ICRS Cartilage Foundation; paid presenter or speaker for Joint Operations UK; editorial or governing board of Knee Surgery, Sports Traumatology, Arthroscopy; paid consultant for and stock or stock options from Orthonika; and paid presenter or speaker for Smith & Nephew. M.J.S. reports paid consultant for and receives royalties from Arthrex and has received research support from Stryker. S.T. reports consulting or advisory with Smith & Nephew and Newclip Technics. M.T. reports board membership with International Society of Arthroscopy Knee Surgery and Orthopaedic Sports Medicine and consulting or advisory with Arthrex. N.N.V. reports hospitality payments from Abbott Laboratories, Axonics, Boston Scientific, Foundation Fusion Solutions LLC, IBSA Pharma, Nalu Medical, Nevro Corp, Orthofix Medical, Pacira Pharmaceuticals Incorporated, Relievant Medsystems, Salix Pharmaceuticals, Vericel Corporation, and Vertos Medial; board or committee member of the American Orthopaedic Society for Sports Medicine, American Shoulder and Elbow Surgeons, and Arthroscopy Association of North America; IP royalties; research support from Arthrex and Smith & Nephew; research support from Breg and Ossur; IP royalties from Graymont Professional Products IP LLC; paid consultant for Medacta USA; educational support from Medwest Associates; editorial or governing board of SLACK Incorporated; travel and lodging from Spinal Simplicity LLC:; and IP royalties, paid consultant, and research support from Stryker. A.Y. reports paid consultant for AlloSource and JRF Ortho; research support from Arthrex and Organogenesis; stock or stock options from Icarus Medical; unpaid consultant and stock or stock options from Patient IQ and Sparta Biomedical; and paid consultant and paid presenter or speaker for Stryker. V.M. reports board or committee member of the ACL Study Group, American Orthopaedic Society for Sports Medicine, International Society of Arthroscopy, Knee Surgery, and Orthopaedic Sports Medicine, and Journal of ISAKOS; other financial or material support from Arthrex; editorial or governing board of Knee Surgery, Sports Traumatology, Arthroscopy: paid consultant for Newclip; stock or stock options from Ostesys; other financial or material support from and paid consultant for Smith & Nephew; and publishing royalties, financial or material support from Springer. All other authors (F.A., L.D., J.R.G., C.G., A.J.B., D.L.B., C.H.B., K.S.C., M.C., L.E., F.F., S.C.F., M.J.F., T.F., T.H., E.I., J.G.K., Y.K., E.K., S.K., C.M.L., D.W.L., C.A.L., I.I.L.T., R.M., G.M., J.K.M., R.N.V., Y.O., J.C.R., E.S., C.S., S-H.K., M.J.T., L.V.T., W.A.v.d.W., R.P.B.v.B.) declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. 18. Asia Pac J Sports Med Arthrosc Rehabil Technol. 2023 Feb 8;31:11-17. doi: 10.1016/j.asmart.2023.01.002. eCollection 2023 Jan. Femoral-varus tibial-valgus osteotomy (FVTVO) for neutrally-aligned knee osteoarthritis with severe joint line obliquity enables return to sports activities: A case series study. Nakamura R(1), Amemiya M(2), Shimakawa T(3), Takahashi M(4), Kuroda K(4), Katsuki Y(4), Okano A(1). Author information: (1)Joint Preservation and Sports Orthopaedic Center, Harue Hospital, Sakai, Fukui, Japan. (2)Department of Joint Surgery and Sports Medicine, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan. (3)Department of Orthopaedic Surgery, Yaese-kai Doujin Hospital, Urasoe, Okinawa, Japan. (4)Department of Orthopaedic Surgery, Yawata Medical Center, Komatsu, Ishikawa, Japan. BACKGROUND: Re-alignment surgeries for uni-compartmental knee osteoarthritis, such as high tibial osteotomy (HTO) for varus knees or distal femoral osteotomy (DFO) for valgus knees, are recognized as standard strategies. However, the treatment strategy has not been established for patients with a neutrally-aligned osteoarthritic knee with severe joint line obliquity (JLO) owing to the combination of a valgus femur and a varus tibia; i.e., type II coronal plane alignment of the knee (CPAK). total knee arthroplasty (TKA) can be an option for CPAK type II-aligned osteoarthritis in older inactive patients. Here, we hypothesized that joint line horizontalization by femoral-varus tibial-valgus osteotomy (FVTVO), which may reduce the shear stress induced by JLO, could be a treatment option for CPAK type II-aligned osteoarthritis in young active patients who wish to return to sports (RTS) activity. Our aim in this study was to evaluate the postoperative results of FVTVO with RTS. METHODS: Our indications for FVTVO are as follows: JLO >5°; mechanical medial proximal tibial angle (mMPTA)